Position in EYPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,787,342
+$419,224 QoQ
Shares Held
124,989
+17.8% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 188 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. EYPT ranks #157 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in EYPT
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,787,342 | 124,989 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,368,118 | 106,138 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,691,253 | 92,570 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,166,426 | 81,912 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $787,701 | 83,709 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,338,755 | 1,354,014 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $15,978,364 | 2,144,747 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $19,912,781 | 2,492,213 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $21,770,626 | 2,502,371 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $50,968,395 | 2,465,815 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $58,299,689 | 2,522,704 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $10,981,024 | 1,374,346 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||